Bain
Asia Pacific medtech demand to reach $132B by 2030, only few companies achieve global scale: Bain report
Asia Pacific's share of global medtech demand is expected to reach $132 billion by 2030, growing at 6.9 percent annually and faster than the global market, according to a new report by Bain & Company.
Japan private equity deal value hits $30B as competition intensifies: Bain report
Japan's private equity (PE) market maintained strong momentum in 2025, with deal value reaching JPY4.8 trillion ($29.8 billion), marking the fifth consecutive year that annual deal value exceeded JPY3 trillion, according to Bain & Company's Japan Private Equity Report 2026.
Why your voice AI still feels like a bot – let’s convo!
The benchmark for voice AI is not whether it answers correctly in a controlled demo. It is whether it can survive real conditions: unstable networks, noisy environments, local accents, code-switching, interruptions, and impatient users.
Southeast Asia private equity stalls to $14B in volatile 2025
Private equity activity in Southeast Asia slowed to $14 billion in 2025, reflecting a broader pattern of volatility across the Asia-Pacific region, as investors grappled with global trade tensions, elevated valuations, and persistent fundraising challenges.
Bain: SEA private equity deal value falls 52% in 2022
Southeast Asia’s (SEA) private equity (PE) market deal value fell 52 percent in 2022 compared to the previous year, with deal count also declining 15 percent year-on-year, Bain & Company (Bain) said Thursday.
